Testing ultrasound and near-infrared light to predict brain bleeding
Part of Brain & nervous system clinical trials.
This study looks at using two noninvasive tools on very preterm newborns to better predict whether an intraventricular hemorrhage (bleeding in the brain’s fluid spaces) may happen. If successful, it could help doctors spot risk earlier and monitor or treat babies sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a preterm baby born at or before 27 weeks and 6 days of pregnancy
- The baby must not have known genetic or birth (congenital) conditions that could affect heart or brain oxygen readings
- There should be no known genetic or congenital problem expected to change how oxygen is measured
- There must not be a comfort-only (palliative) care plan before or right after birth
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a light therapy device in newborns who had a severe form of brain bleeding (intraventricular hemorrhage grade 3 or 4) within the first month of life. The goal is to see if this non-invasive treatment may help improve recovery.
This study uses a safe ultrasound test (Doppler) to look at blood flow in the brains of newborn babies. It aims to see how blood flow differs between full-term and preterm infants, which could help doctors understand and support brain health in the first days of life.
This study looks at premature babies who are born very early and weigh very little, to understand bleeding in the brain (called intraventricular hemorrhage). If your baby is eligible, the research may help doctors learn more about this condition and how to manage it.
This study looks at ways to prevent, find early, and manage bleeding in the brain and the fluid buildup that can follow in premature babies. If your baby had such bleeding and fluid buildup, the study may offer close monitoring and care to help improve outcomes.
This trial tests a procedure called neuroendoscopic lavage, which uses a small camera and fluid to gently wash out blood from the fluid spaces in a newborn's brain after a severe bleeding. It aims to reduce pressure and help prevent further damage.
This study tests a special, non-invasive sensor (near-infrared light) to help doctors choose the best cooling treatment for some newborns after brain injury. It may improve how well cooling works and how safely it’s managed in the first week of life.
Hear when a new Intraventricular Hemorrhage of Newborn Grade 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.